Erasca
Latest round
- Series B
Last raised
- Aug 2020
Total raised
- $201M
Investors
- 12
About Erasca
Based in California, US, and founded in 2018, Erasca, Inc. operates as a biotechnology company that focuses on developing drugs for the treatment of cancer. The company's name is a combination of the words erase cancer and was founded by Jonathan E. Lim. Erasca filed confidentially on the NASDAQ in May 2021 to become a public company under the ticker symbol ERAS. The company has 102 employees. The company develops OPRA™, an AI-based platform that provides cancer biology insights. Erasca's drugs are developed through multiple discovery programs that are biological drivers of cancer, and the company is pursuing additional pipeline expansion opportunities through academic and biopharmaceutical collaborations, offering patients with new possible ways to treat and cure cancer. The company as of 2021 has five clinical-stage programs, including ERAS-007. Erasca will begin its enrollment of a Phase 1b/2 trial in advanced solid tumors in May 2021. The company plans to begin three more Phase 1b/2a trials for ERAS-007 in other cancer indications by the first quarter of 2022.
Who invested in Erasca
12 investors across 4 rounds
See all investors in Erasca
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Erasca
Who invested in Erasca?
Erasca has 12 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Erasca raised?
Erasca has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Erasca last raise money?
Erasca's most recent round on record is a Series B, in Aug 2020.
What does Erasca do?
Based in California, US, and founded in 2018, Erasca, Inc.
Where is Erasca headquartered?
Erasca is headquartered in San Diego, US.
Which VCs invest in companies like Erasca?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Erasca's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Erasca? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.